Depiction of Microglial Activation in Aging and Dementia: Positron Emission Tomography with [C]DPA713 Versus [C]( R)PK11195

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2016 Apr 28

PMID 27117856

Citations 45

Authors

Masamichi Yokokura

Tatsuhiro Terada

Tomoyasu Bunai

Kyoko Nakaizumi

Kiyokazu Takebayashi

Yasuhide Iwata

Etsuji Yoshikawa

Masami Futatsubashi

Katsuaki Suzuki

Norio Mori

Yasuomi Ouchi

Affiliations

Soon will be listed here.

Abstract

The presence of activated microglia in the brains of healthy elderly people is a matter of debate. We aimed to clarify the degree of microglial activation in aging and dementia as revealed by different tracers by comparing the binding potential (BP) in various brain regions using a first-generation translocator protein (TSPO) tracer [C]( R)PK11195 and a second-generation tracer [C]DPA713. The BP levels, estimated using simplified reference tissue models, were compared among healthy young and elderly individuals and patients with Alzheimer's disease (AD) and were correlated with clinical scores. An analysis of variance showed category-dependent elevation in levels of [C]DPA713 BP in all brain regions and showed a significant increase in the AD group, whereas no significant changes among groups were found when [C]( R)PK11195 BP was used. Cognito-mnemonic scores were significantly correlated with [C]DPA713 BP levels in many brain regions, whereas [C]( R)PK11195 BP failed to correlate with the scores. As mentioned elsewhere, the present results confirmed that the second-generation TSPO tracer [C]DPA713 has a greater sensitivity to TSPO in both aging and neuronal degeneration than [C]( R)PK11195. Positron emission tomography with [C]DPA713 is suitable for the delineation of in vivo microglial activation occurring globally over the cerebral cortex irrespective of aging and degeneration.

Citing Articles

Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications.

Roveta F, Bonino L, Piella E, Rainero I, Rubino E Int J Mol Sci. 2024; 25(22).

PMID: 39596011 PMC: 11593837. DOI: 10.3390/ijms252211941.

The development status of PET radiotracers for evaluating neuroinflammation.

Lee N, Choi J, Ryu Y Nucl Med Mol Imaging. 2024; 58(4):160-176.

PMID: 38932754 PMC: 11196502. DOI: 10.1007/s13139-023-00831-4.

Translocator protein (18 kDa) positron emission tomography imaging as a biomarker of neuroinflammation in epilepsy.

Qin L, Xiao L, Zhu H, Du Y, Tang Y, Feng L Neurol Sci. 2024; 45(11):5201-5211.

PMID: 38879831 DOI: 10.1007/s10072-024-07648-9.

Neuroinflammation in dementia: A meta-analysis of PET imaging studies.

Pan J, Hu J, Meng D, Chen L, Wei X Medicine (Baltimore). 2024; 103(18):e38086.

PMID: 38701247 PMC: 11062685. DOI: 10.1097/MD.0000000000038086.

Neuroinflammation following anti-parkinsonian drugs in early Parkinson's disease: a longitudinal PET study.

Terada T, Bunai T, Hashizume T, Matsudaira T, Yokokura M, Takashima H Sci Rep. 2024; 14(1):4708.

PMID: 38409373 PMC: 10897150. DOI: 10.1038/s41598-024-55233-z.

References

Lim G, Yang F, Chu T, Chen P, BEECH W, Teter B . Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000; 20(15):5709-14. PMC: 6772529. View

Yasuno F, Ota M, Kosaka J, Ito H, Higuchi M, Doronbekov T . Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry. 2008; 64(10):835-41. DOI: 10.1016/j.biopsych.2008.04.021. View

Wilcock D, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J . Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci. 2004; 24(27):6144-51. PMC: 6729674. DOI: 10.1523/JNEUROSCI.1090-04.2004. View

Ouchi Y, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M . Altered glucose metabolism in the hippocampal head in memory impairment. Neurology. 1998; 51(1):136-42. DOI: 10.1212/wnl.51.1.136. View

Venneti S, Wang G, Nguyen J, Wiley C . The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol. 2008; 67(10):1001-10. PMC: 2669281. DOI: 10.1097/NEN.0b013e318188b204. View

Gulyas B, Makkai B, Kasa P, Gulya K, Bakota L, Varszegi S . A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor.... Neurochem Int. 2008; 54(1):28-36. DOI: 10.1016/j.neuint.2008.10.001. View

Dickens A, Vainio S, Marjamaki P, Johansson J, Lehtiniemi P, Rokka J . Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med. 2014; 55(3):466-72. DOI: 10.2967/jnumed.113.125625. View

Schuitemaker A, Kropholler M, Boellaard R, van der Flier W, Kloet R, van der Doef T . Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Neurobiol Aging. 2012; 34(1):128-36. DOI: 10.1016/j.neurobiolaging.2012.04.021. View

Wiley C, Lopresti B, Venneti S, Price J, Klunk W, DeKosky S . Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch Neurol. 2009; 66(1):60-7. PMC: 2666881. DOI: 10.1001/archneurol.2008.511. View

10.

Barrientos R, Kitt M, Watkins L, Maier S . Neuroinflammation in the normal aging hippocampus. Neuroscience. 2015; 309:84-99. PMC: 4567963. DOI: 10.1016/j.neuroscience.2015.03.007. View

11.

Lekander M, von Essen J, Schultzberg M, Andreasson A, Garlind A, Hansson L . Cytokines and memory across the mature life span of women. Scand J Psychol. 2011; 52(3):229-35. DOI: 10.1111/j.1467-9450.2010.00865.x. View

12.

Frank M, Barrientos R, Watkins L, Maier S . Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo. J Neuroimmunol. 2010; 226(1-2):181-4. PMC: 2937085. DOI: 10.1016/j.jneuroim.2010.05.022. View

13.

Barrientos R, Hein A, Frank M, Watkins L, Maier S . Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J Neurosci. 2012; 32(42):14641-8. PMC: 3492959. DOI: 10.1523/JNEUROSCI.2173-12.2012. View

14.

Cagnin A, Brooks D, Kennedy A, Gunn R, Myers R, Turkheimer F . In-vivo measurement of activated microglia in dementia. Lancet. 2001; 358(9280):461-7. DOI: 10.1016/S0140-6736(01)05625-2. View

15.

McGeer P, McGeer E . NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging. 2006; 28(5):639-47. DOI: 10.1016/j.neurobiolaging.2006.03.013. View

16.

Abraham J, Johnson R . Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice. Rejuvenation Res. 2010; 12(6):445-53. PMC: 2903454. DOI: 10.1089/rej.2009.0888. View

17.

Endres C, Pomper M, James M, Uzuner O, Hammoud D, Watkins C . Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med. 2009; 50(8):1276-82. PMC: 2883612. DOI: 10.2967/jnumed.109.062265. View

18.

McGeer E, McGeer P . The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol. 1998; 33(5):371-8. DOI: 10.1016/s0531-5565(98)00013-8. View

19.

Barrientos R, Frank M, Crysdale N, Chapman T, Ahrendsen J, Day H . Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J Neurosci. 2011; 31(32):11578-86. PMC: 3171131. DOI: 10.1523/JNEUROSCI.2266-11.2011. View

20.

Golla S, Boellaard R, Oikonen V, Hoffmann A, van Berckel B, Windhorst A . Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients. J Cereb Blood Flow Metab. 2015; 35(5):766-72. PMC: 4420859. DOI: 10.1038/jcbfm.2014.261. View